Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III vedolizumab in Japanese patients with moderate to severe Crohn's disease
jRCT2080222352Phase 3Completed
- Sponsor
- Takeda
- Start
- Dec 2013
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in Crohn's disease comparing Vedolizumab with Placebo (2 arms). Started Dec 2013; status: completed.
02
Drugs
vedolizumab
03
Conditions
Crohn's disease
Beyond the preview
Go deeper on jRCT2080222352.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080222352.